• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Advances in Drug Resistance Research

Advances in Drug Resistance Research

9781631171314
900.84 zł
810.75 zł Save 90.09 zł Tax included
Lowest price within 30 days before promotion: 810.75 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
Drug resistance continues to be a major problem in the effective treatment of many diseases. Resistance to chemotherapy, whether intrinsic or extrinsic, is the result of at least three well defined mechanisms:: prevention of the interaction of drug with the target, decreased intracellular concentration of the drug due to an increased efflux or a decreased influx, and enzymatic modification or destruction of the drug. With the advancement in technology, the molecular mechanisms of drug resistance have been unravelling at a rapid rate. This book is a timely review of such advances in drug resistance research. The nine chapters of this book, written by a group of clinicians and scientists, elegantly summarises recent advances in our understanding of this important clinical problem with emphasis on cisplatin, fibroblasts, natural compounds, erythropoiesis-stimulating agents, prostate cancer and kidney cancer. This book will be an important contribution to science, and an invaluable tool for researchers who are interested in drug resistance.
Product Details
74491
9781631171314
9781631171314

Data sheet

Publication date
2014
Issue number
1
Cover
hard cover
Pages count
220
Dimensions (mm)
155.00 x 230.00
Weight (g)
520
  • Mechanisms of Cisplatin Resistance:: DNA Repair & Cellular Implications; Multi-Drug Resistance in Cancer & New Approaches for its Overcoming; Tumor Fibroblasts:: Pivotal Players in Drug Resistance; Erythropoiesis Stimulating Agent Resistance; Therapeutic Options for Metastatic Castration Resistant Prostate Cancer:: Has the Situation Improved?; Current Trends in Prostate Cancer Treatment & Drug Resistance; Resistance of Metastatic Renal Cell Carcinomas to Chemo & Immunotherapy:: Clinicians Perspective; Resistance of Renal Cell Carcinoma to Targeted Therapy; Molecular Mechanisms of Sunitinib Resistance in Renal Cell Carcinoma.
Comments (0)